NewEdge Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$321K Buy
3,553
+571
+19% +$52.4K ﹤0.01% 2293
2025
Q4
$268K Buy
2,982
+203
+7% +$19.2K ﹤0.01% 2382
2025
Q3
$274K Buy
2,779
+2,018
+265% +$200K ﹤0.01% 2233
2025
Q2
$69.4K Sell
761
-1,640
-68% -$159K ﹤0.01% 2564
2025
Q1
$272K Sell
2,401
-2,312
-49% -$247K ﹤0.01% 1958
2024
Q4
$498K Buy
4,713
+1,983
+73% +$213K ﹤0.01% 1556
2024
Q3
$295K Sell
2,730
-239
-8% -$26.1K ﹤0.01% 1810
2024
Q2
$322K Sell
2,969
-989
-25% -$117K ﹤0.01% 1678
2024
Q1
$522K Sell
3,958
-404
-9% -$50.5K ﹤0.01% 1323
2023
Q4
$531K Sell
4,362
-3,069
-41% -$342K 0.01% 1256
2023
Q3
$834K Sell
7,431
-1,605
-18% -$204K 0.01% 947
2023
Q2
$1.32M Sell
9,036
-599
-6% -$81.4K 0.01% 745
2023
Q1
$1.31M Sell
9,635
-110
-1% -$13.8K 0.02% 685
2022
Q4
$1.21M Buy
9,745
+3,191
+49% +$370K 0.03% 457
2022
Q3
$685K Buy
6,554
+3,674
+128% +$403K 0.01% 814
2022
Q2
$303K Buy
+2,880
New +$342K 0.01% 1210
2022
Q1
Sell
-3,197
Closed -$394K 1680
2021
Q4
$394K Buy
+3,197
New +$418K 0.01% 1193

Other funds holding ZBH

NewEdge Advisors's ZBH Position: Q1 2026 in Review

NewEdge Advisors increased its Zimmer Biomet (ZBH) stake by 19% in Q1 2026, buying an estimated $52.4K and bringing the position to 3,553 shares worth $321K. The position accounts for ﹤0.01% of the portfolio, ranked #2293.

NewEdge Advisors first reported a position in ZBH in Q4 2021 and has held it in 17 quarters since. The position peaked at $1.32M in Q2 2023. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • NewEdge Advisors held 3,553 shares of Zimmer Biomet worth $321K as of Q1 2026.
  • NewEdge Advisors bought 571 Zimmer Biomet shares in Q1 2026, an estimated $52.4K.
  • Zimmer Biomet made up ﹤0.01% of NewEdge Advisors's portfolio in Q1 2026, its #2293 holding.
  • NewEdge Advisors first reported a position in Zimmer Biomet in Q4 2021 and has held it in 17 quarters since.
  • NewEdge Advisors's Zimmer Biomet position peaked at $1.32M in Q2 2023.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.